Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany.
Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany.
Gut. 2023 Mar;72(3):522-534. doi: 10.1136/gutjnl-2021-326550. Epub 2022 Aug 9.
Due to the limited number of modifiable risk factors, secondary prevention strategies based on early diagnosis represent the preferred route to improve the prognosis of pancreatic ductal adenocarcinoma (PDAC). Here, we provide a comparative morphogenetic analysis of PDAC precursors aiming at dissecting the process of carcinogenesis and tackling the heterogeneity of preinvasive lesions.
Targeted and whole-genome low-coverage sequencing, genome-wide methylation and transcriptome analyses were applied on a final collective of 122 morphologically well-characterised low-grade and high-grade PDAC precursors, including intestinal and gastric intraductal papillary mucinous neoplasms (IPMN) and pancreatic intraepithelial neoplasias (PanIN).
Epigenetic regulation of mucin genes determines the phenotype of PDAC precursors. PanIN and gastric IPMN display a ductal molecular profile and numerous similarly regulated pathways, including the Notch pathway, but can be distinguished by recurrent deletions and differential methylation and, in part, by the expression of mucin-like 3. Intestinal IPMN are clearly distinct lesions at the molecular level with a more instable genotype and are possibly related to a different ductal cell compartment.
PDAC precursors with gastric and intestinal phenotype are heterogeneous in terms of morphology, genetic and epigenetic profile. This heterogeneity is related to a different cell identity and, possibly, to a different aetiology.
由于可改变的风险因素数量有限,基于早期诊断的二级预防策略代表了改善胰腺导管腺癌(PDAC)预后的首选途径。在这里,我们对 PDAC 前体进行了比较形态发生分析,旨在剖析癌变过程并解决侵袭前病变的异质性。
靶向和全基因组低覆盖测序、全基因组甲基化和转录组分析应用于最终共 122 个形态学特征良好的低级别和高级别 PDAC 前体,包括肠内和胃内导管内乳头状黏液性肿瘤(IPMN)和胰腺上皮内瘤变(PanIN)。
粘蛋白基因的表观遗传调控决定了 PDAC 前体的表型。PanIN 和胃 IPMN 显示出导管分子谱,并且存在许多类似调节的途径,包括 Notch 途径,但可以通过反复缺失和差异甲基化来区分,部分通过粘蛋白样 3 的表达来区分。肠内 IPMN 在分子水平上是明显不同的病变,具有更不稳定的基因型,可能与不同的导管细胞区室有关。
在形态、遗传和表观遗传特征方面,具有胃和肠表型的 PDAC 前体具有异质性。这种异质性与不同的细胞身份有关,可能与不同的病因有关。